Boehringer Ingelheim Vetmedica Gmbh

Franz Wilhelm

Otto Kern

Ernst Salamon

An antibacterial substance which does not have optimum absorbability and is administered parentally into tissue, is administered to a host in conjunction with a benzylamine derivative of the formula ##STR1## wherein R.sub.1 is hydroxyl in the 2- or 4-position or amino in the 2-position;

Method of improving the absorption of injected antibacterial substances

This invention relates to a method of improving the resorption of injected antibacterially active substances or combinations. More specifically, this invention relates to a method of increasing the resorption of an antibacterially active substance or combination which does not have optimum resorbability and which is administered parenterally into tissue, which comprises administering to a host at least one benzylamine derivative of the formula ##STR1## wherein R.sub.1 is a hydroxyl group in the 2- or 4-position or an amino group in the 2-position;

Method of improving resorption of injected antibacterially active

The invention relates to the use of a substance as a sedative with an analgesic and bradycardiac effect in warm-blooded animals. The possible applications are, for example, in the field of veterinary medicine for general tranquilizing and for producing analgesia.

Growing community of inventors

Ingelheim am Rhein, Germany

Franz Wilhelm